Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
9.09
Nov 12 • 3:59 PM ET Dollar change-0.01 Percentage change(-0.11%)
Aftermarket Close
9.06
Aftermarket • 6:50 PM ET Dollar change-0.03 Percentage change(-0.29%)
Index
-
Market Cap
39.90B
Enterprise Value
49.83B
Income
2.18B
Sales
14.97B
Book/sh
4.96
Cash/sh
0.25
Employees
-
IPO
Jul 18, 2022
P/E
18.69
Forward P/E
15.31
PEG
1.96
P/S
2.67
P/B
1.83
P/C
36.39
P/FCF
14.50
EV/EBITDA
12.58
EV/Sales
3.33
Quick Ratio
0.52
Current Ratio
0.69
Debt/Eq
0.50
LT Debt/Eq
0.38
Option/Short
Yes / Yes
EPS (ttm)
0.49
EPS next Y
0.59
EPS next Q
0.15
EPS this Y
9.64%
EPS next Y
6.44%
EPS next 5Y
7.82%
EPS past 3/5Y
20.04% 9.00%
Sales past 3/5Y
2.82% 2.76%
EPS Y/Y TTM
12.37%
Sales Y/Y TTM
4.99%
EPS Q/Q
24561.95%
Sales Q/Q
15.22%
Insider Own
0.00%
Insider Trans
-
Inst Own
14.11%
Inst Trans
-0.14%
ROA
5.02%
ROE
9.99%
ROIC
7.24%
Gross Margin
65.46%
Oper. Margin
23.31%
Profit Margin
14.55%
SMA20
-4.29%
SMA50
-2.80%
SMA200
-6.41%
Trades
Shs Outstand
4.39B
Shs Float
4.39B
52W High
11.28 -19.41%
52W Low
8.38 8.47%
Volatility
2.17% 1.96%
ATR (14)
0.25
RSI (14)
44.24
Beta
0.13
Rel Volume
1.01
Avg Volume
18.00M
Volume
18,244,982
Perf Week
-0.66%
Perf Month
-6.10%
Perf Quarter
-6.29%
Perf Half Y
2.02%
Perf YTD
-10.09%
Perf Year
-8.00%
Perf 3Y
12.36%
Perf 5Y
-
Perf 10Y
-
Prev Close
9.10
Price
9.09
Change %
-0.11%
Consensus
Buy
Avg. Price Target
$10.21
Implied Upside
+12.3%
Analysts11incl. previous ratings
Rating Distribution6 Buy · 5 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Nov 04, 2026Downgrade
JEF logoJJefferies
Buy → Hold
Oct 30, 2026Upgrade
DB logoDDeutsche Bank
Sell → Hold
Jan 23, 2026Upgrade
BCS logoBBarclays
Equal Weight → Overweight
Sep 16, 2025Downgrade
BCS logoBBarclays
Overweight → Equal Weight
Sep 10, 2025Upgrade
GS logoGGoldman
Neutral → Buy
May 27, 2025Upgrade
BBNP Paribas Exane
Neutral → Outperform$13.40+47.4%
May 09, 2025Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight$11.25+23.8%
Mar 05, 2025Downgrade
HSBC logoHHSBC Securities
Buy → Hold
Jan 10, 2025Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Jan 08, 2025Downgrade
BBernstein
Outperform → Mkt Perform
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
CEO & Executive DirectorMr. Brian James McNamara
CFO & DirectorMs. Dawn Amanda Allen
Chief Digital & Technology OfficerMs. Claire Dickson
Head of Investor RelationsMs. Joanne Russell
General CounselMr. Adrian Charles Morris